Evidence map›Paper›PMID 27543037›Full record

ArticleBMC public health2016

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Severin Kabakama, Katherine E Gallagher, Natasha Howard, Sandra Mounier-Jack, Helen E D Burchett, Ulla K Griffiths, Marta Feletto, D Scott LaMontagne, Deborah Watson-Jones

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Observational
  7. Article
  8. Review
  9. Developing Community-Informed Communication Resources to Improve Human Papillomavirus Vaccine Uptake in Tonga.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Severin KabakamaMwanza Intervention Trials Unit, National Institute for Medical Research, PO Box 11936, Mwanza, Tanzania.
Katherine E GallagherMwanza Intervention Trials Unit, National Institute for Medical Research, PO Box 11936, Mwanza, Tanzania. Katherine.Gallagher@lshtm.ac.uk.ORCID 0000-0002-5604-7647
Natasha HowardDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, Tavistock Place, London, WC1H 9SH, UK.
Sandra Mounier-JackDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, Tavistock Place, London, WC1H 9SH, UK.
Helen E D BurchettDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, Tavistock Place, London, WC1H 9SH, UK.
Ulla K GriffithsDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, Tavistock Place, London, WC1H 9SH, UK.
Marta FelettoPATH, Vaccine Access and Delivery, PO Box 900922, Seattle, WA, 98109, USA.
D Scott LaMontagnePATH, Vaccine Access and Delivery, PO Box 900922, Seattle, WA, 98109, USA.
Deborah Watson-JonesMwanza Intervention Trials Unit, National Institute for Medical Research, PO Box 11936, Mwanza, Tanzania.
London School of Hygiene & Tropical Medicine · GBProgram for Appropriate Technology in Health · USUniversity of London · GBMwanza Intervention Trials Unit · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSocial mobilisation during new vaccine introductions encourages acceptance, uptake and adherence to multi-dose schedules. Effective communication is considered especially important for human papillomavirus (HPV) vaccine, which targets girls of an often-novel age group. This study synthesised experiences and lessons learnt around social mobilisation, consent, and acceptability during 55 HPV vaccine demonstration projects and 8 national programmes in 37 low and middle-income countries (LMICs) between January 2007 and January 2015.

methodsA qualitative study design included: (i) a systematic review, in which 1,301 abstracts from five databases were screened and 41 publications included; (ii) soliciting 124 unpublished documents from governments and partner institutions; and (iii) conducting 27 key informant interviews. Data were extracted and analysed thematically. Additionally, first-dose coverage rates were categorised as above 90 %, 90-70 %, and below 70 %, and cross-tabulated with mobilisation timing, message content, materials and methods of delivery, and consent procedures.

resultsAll but one delivery experience achieved over 70 % first-dose coverage; 60 % achieved over 90 %. Key informants emphasized the benefits of starting social mobilisation early and actively addressing rumours as they emerged. Interactive communication with parents appeared to achieve higher first-dose coverage than non-interactive messaging. Written parental consent (i.e., opt-in), though frequently used, resulted in lower reported coverage than implied consent (i.e., opt-out). Protection against cervical cancer was the primary reason for vaccine acceptability, whereas fear of adverse effects, exposure to rumours, lack of project/programme awareness, and schoolgirl absenteeism were major reasons for non-vaccination.

conclusionsDespite some challenges in obtaining parental consent and addressing rumours, experiences indicated effective social mobilisation and high HPV vaccine acceptability in LMICs. Social mobilisation, consent, and acceptability lessons were consistent across world regions and HPV vaccination projects/programmes. These can be used to guide HPV vaccination communication strategies without additional formative research.

Indexed as

CommunicationDeveloping CountriesPatient Acceptance of Health CareSocial EnvironmentVaccinationAdolescentAwarenessChildFemaleGovernment ProgramsHumansMalePapillomavirus InfectionsPapillomavirus VaccinesParentsProgram EvaluationPapillomavirus VaccinesAcceptabilityCommunicationConsentHPVLMICsMobilisationVaccination

Identifiers

PMID27543037
PMCPMC4992325
OpenAlexW2507851472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.